Midwest Surgical Alliance, LLC
$3.0M 30 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Augmedics Inc.
Augmedics Inc. reported $2,977,582.24 across General Payments, Research, and Ownership to 798 physicians and teaching hospitals across 816 transactions.
- $3.0M Top quartile payer
- All-tracks total
- 816 Above-median volume
- Transactions
- 798 Above-median reach
- Recipients
- −$28.2K
- General Payments vs PY2023
Augmedics Inc. reported $2,977,582.24 across all CMS Open Payments tracks (General + Research + Ownership) to 798 physicians and teaching hospitals in Program Year 2024 - ranking #364 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $233,655.85, averaging $3.7K per recipient.
How Augmedics Inc.'s $3.0M all-tracks total breaks down
Augmedics Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
30/100
Total payments
F
37/100
Transaction volume
F
16/100
Physician reach
F
16/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer augmedics-inc Augmedics Inc.
$3.0M · #364/1,925 · 0.0% industry · PY2024
- TOT $3.0M
- RANK #364
- SHARE 0.0%
- TXN 816
- RCP 798
- CAT 4
- GEN $233.7K
- ΔGEN −$28.2K
- TOP1 7.6%
- PY 2024
Volume peers
Nearest volume peer: Midwest Surgical Alliance, LLC ($3.0M)
Augmedics Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Augmedics Inc.'s CMS-reported General Payments decreased by $28.2K (−10.8%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: AUGMEDICS INC.PY2023: AUGMEDICS INC.PY2024: Augmedics Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $261,808.68
- PY2024
- $233,655.85
What the Data Shows for Augmedics Inc.
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Augmedics Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $150.7K across 78 transactions, 64.5% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Augmedics Inc.'s 4-category general-payment breakdown at $150.7K, 64.5% of the reported total.
Augmedics Inc. reports 4 general-payment categories - the top three are Consulting Fee (64.5%), Food and Beverage (20.0%), and Travel and Lodging (15.4%). The remaining 1 category make up 0.0% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Augmedics Inc. divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $150.7K | 78 | 64.5% |
| Food and Beverage | $46.8K | 661 | 20.0% |
| Travel and Lodging | $36.1K | 58 | 15.4% |
| Gift | $75.81 | 1 | 0.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $74,693.95 (32.0%) of $233,655.85 in this company's General Payments records across 403 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Augmedics Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Rajiv K Sethi
$17,649.18 across 19 reported transactions
- 2
Neil Vasishta Patel
$15,000.00 across 1 reported transactions
- 3
Philip Louie
$14,705.05 across 27 reported transactions
- 4
Augustus John Rush
$14,089.43 across 45 reported transactions
- 5
Safdar N Khan
$13,250.29 across 12 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Augmedics Inc. ranks #364 of 1,925 by total payments (top 19% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,387 of 1,838 by HHI (bottom 25% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Sonendo Inc : $1.3M total payments, HHI 386
- Astellas Pharma Global Development : $662.0K total payments, HHI 386
- Breg, Inc : $959.96 total payments, HHI 385
- Impulse Dynamics (USA) Inc. : $1.3M total payments, HHI 385
- Medela LLC : $63.1K total payments, HHI 384
- Ovesco Endoscopy USA, Inc. : $61.0K total payments, HHI 384
- Augmedics Inc. (this company) : $233.7K total payments, HHI 383
- Daiichi Sankyo Inc. : $6.9M total payments, HHI 382
- Biocomposites Inc : $138.8K total payments, HHI 381
- Dental Health Products, Inc. : $7.5K total payments, HHI 380
- XVIVO Perfusion Inc. : $51.8K total payments, HHI 377
- Carl Zeiss Meditec, Inc. : $938.6K total payments, HHI 376
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Augmedics Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Augmedics Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Augmedics Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Hinge Health, Inc.
$3.0M 21 recipients
Compare payment profiles
Medline Industries LP
$3.0M 4,842 recipients
Compare payment profiles
Hologic Inc
$3.0M 432 recipients
Compare payment profiles
CathWorks, Inc.
$2.9M 241 recipients
Compare payment profiles
LENSAR, Inc.
$3.0M 331 recipients
Compare payment profiles
Put this to use
Augmedics Inc. ranks #364 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Augmedics Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Augmedics Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.